CIE-10

CIE-10-código Y56

You are here: Inicio > CIE-10 > V01-Y99 > Y40-Y84 > Y40-Y59

- CIE-10
Clasificación Internacional de Enfermedades
- V01-Y99
Causas externas de morbilidad y de mortalidad
- Y40-Y84
Complicaciones de la atención médica y quirúrgica
- Y40-Y59
Drogas, medicamentos y sustancias biológicas causantes de efectos adversos en su uso terapéutico

Y56

Efectos adversos de agentes tópicos que afectan primariamente la piel y las membranas mucosas, y drogas oftalmológicas, otorrinolaringológicas y dentales

CIE-10 Сódigo Y56 para Efectos adversos de agentes tópicos que afectan primariamente la piel y las membranas mucosas, y drogas oftalmológicas, otorrinolaringológicas y dentales

Incluye: glucocorticoides de uso tópico

Y56.0
Efectos adversos de drogas antimicóticas, antiinfecciosas y antiinflamatorias de uso local, no clasificadas en otra parte
Y56.1
Efectos adversos de antipruriginosos
Y56.2
Efectos adversos de astringentes y detergentes locales
Y56.3
Efectos adversos de emolientes, demulcentes y protectores
Y56.4
Efectos adversos de drogas y preparados queratolíticos, queratoplásticos y otros para el tratamiento del cabello
Y56.5
Efectos adversos de drogas y preparados oftalmológicos
Y56.6
Efectos adversos de drogas y preparados otorrinolaringológicos
Y56.7
Efectos adversos de drogas dentales, de aplicación tópica
Y56.8
Efectos adversos de otros agentes tópicos
Y56.9
Efectos adversos de otros agentes tópicos no especificados
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us